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Abstract
Background: In Myanmar, postpartum haemorrhage is the leading cause of maternal mortality and contributes to
around 30% of all maternal deaths. The World Health Organization recommends training and supporting auxiliary
midwives to administer oral misoprostol for prevention of postpartum haemorrhage in resource-limited settings.
However, use of misoprostol by auxiliary midwives has not formally been approved in Myanmar. Our study aimed
to explore community and provider perspectives on the roles of auxiliary midwives and community-level provision
of oral misoprostol by auxiliary midwives.
Methods: A qualitative inquiry was conducted in Ngape Township, Myanmar. A total of 15 focus group discussions
with midwives, auxiliary midwives, community members and mothers with children under the age of three were
conducted. Ten key informant interviews were performed with national, district and township level health planners
and implementers of maternal and child health services. All audio recordings were transcribed verbatim in Myanmar
language. Transcripts of focus group discussions were fully translated into English before coding, while key informants’
data were coded in Myanmar language. Thematic analysis was done using ATLAS.ti software.
Results: Home births are common and auxiliary midwives were perceived as an essential care provider during childbirth
in hard-to-reach areas. Main reasons provided were that auxiliary midwives are more accessible than midwives, live in the
hard-to-reach areas, and are integrated in the community and well connected with midwives. Auxiliary midwives
generally reported that their training involved instruction on active management of the third stage of labour, including
use of misoprostol, but not all auxiliary midwives reported using misoprostol in practice. Supportive reasons for task-
shifting administration of oral misoprostol to auxiliary midwives included discussions around the good relationship and
trust between auxiliary midwives and midwives, whereby midwives felt confident distributing misoprostol to auxiliary
midwives. However, the lack of clear government-level written permission to distribute the drug was perceived as a
barrier to task shifting.
(Continued on next page)
* Correspondence: stanley.luchters@burnet.edu.au
1Burnet Institute, Melbourne, Australia
5Department of Epidemiology and Preventive Medicine and Central Clinical
School, Monash University, Melbourne, Australia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Than et al. BMC Pregnancy and Childbirth  (2017) 17:146 
DOI 10.1186/s12884-017-1324-6
(Continued from previous page)
Conclusion: This study highlights the acceptability of misoprostol use by auxiliary midwives to prevent postpartum
haemorrhage, and findings suggest that it should be considered as a promising intervention for task shifting in
Myanmar.
Keywords: Maternal health, Community-based care, Oral misoprostol, Postpartum haemorrhage, Auxiliary midwives,
Task shifting, Qualitative inquiry, Myanmar
Background
Maternal mortality remains a major challenge to
health systems worldwide. Globally, there were an
estimated 303,000 maternal deaths in 2015 [1]. The
leading cause of maternal mortality in low-income
countries is postpartum haemorrhage, which is the
primary cause of nearly one fifth of all maternal
deaths worldwide [2]. Postpartum haemorrhage is
commonly defined as a blood loss of 500 ml or more
within 24 h after birth. In many cases, postpartum
haemorrhage after birth is preventable through use of
prophylactic uterotonics during the third stage of
labour with timely and appropriate care and manage-
ment [3].
In Myanmar, it is estimated that the maternal mortal-
ity ratio decreased from 360 to 200 per 100,000 live
births between 2000 and 2013 [1]. However, according
to a nationwide cause-specific maternal mortality survey,
postpartum haemorrhage remains responsible for an es-
timated 30% of all maternal deaths, making it the leading
cause of maternal mortality in the country [4]. Urgent
actions are being taken by the Government of Myanmar
to bring down the high rate of maternal mortality,
recognising the human resource shortage in hard-to-
reach areas as one of the main causes. Inadequate health
literacy in the community, being responsible for too
many women, and poor accessibility are some of the
challenges faced by skilled birth attendants assigned to
rural hard-to-reach areas [5]. One of the mechanisms
that the Ministry of Health has employed is to promote
the existence of auxiliary midwives (AMWs) with the
aim of “one AMW to be trained in every village” by
2016 [6]. AMWs are categorized as unpaid volunteer
health workers and have been part of the health system
since the late 1970s [7]. AMWs are mostly local women
with secondary level of education, who have been
selected and trained under the guidance of the Township
Health Department for three months in theory and three
months in practical skills related to antenatal care,
uncomplicated deliveries and postnatal care. The main
role of AMWs is to perform preventive care such as
counselling of mothers on safe motherhood and promot-
ing delivery with a skilled attendant. AMWs are to assist
midwives (MW), who are skilled birth attendants from
the formal health sector.
When a skilled birth attendant is available, the most
effective intervention for preventing postpartum haem-
orrhage is active management of third stage of labour
which includes administration of a uterotonic drug after
the birth of the baby, controlled cord traction, and uter-
ine massage. Active management of third stage of labour
using oxytocin injection as the preferred uterotonic is
current best practice for prevention of postpartum
haemorrhage [3, 8, 9]. However, the need for cold chain
storage and a skilled provider to administer an injection
hinders the distribution and usage of oxytocin in many
resource-limited settings, particularly in more remote
communities [10].
Misoprostol is an oral uterotonic drug suggested as a
substitute to oxytocin in low resource settings [11, 12].
As this drug does not require cold storage and can be
administered orally, it has been used and proven to be
effective when administered by community health
workers to prevent postpartum haemorrhage in several
countries [13–16]. Current World Health Organization
(WHO) task shifting guidelines specifically recommend
misoprostol use by AMWs in situations where there are
no skilled birth attendants and home births are common
[17]. In Myanmar, 70% of the population resides in rural
areas where home births are a common practice [18].
Although AMWs in Myanmar are categorized as
unskilled birth attendants, current training manuals in-
clude the topic on active management of the third stage
of labour with the use of misoprostol [19]. However, use
of uterotonics including misoprostol by AMWs remains
controversial due to concerns regarding the manage-
ment of possible side-effects such as fever and chills,
and the potential use of misoprostol to induce abortion.
This study aimed to explore community and provider
perspectives on the role of AMWs and explore
community-level provision of oral misoprostol by AMWs.
Methods
To understand the barriers and facilitators towards task
shifting of AMWs in Myanmar, we undertook a descrip-
tive mixed methods study. This paper reports on the
qualitative research component of the study.
The qualitative inquiry was conducted in Ngape
Township (an administrative subdivision of a district) in
Myanmar. Ngape Township was purposefully chosen
Than et al. BMC Pregnancy and Childbirth  (2017) 17:146 Page 2 of 10
because it is a hard-to-reach township, some 16 h driv-
ing from Yangon. Ngape Township has an estimated
population of 46,572 and has one township hospital, one
station hospital and three rural health centres.
The consolidated criteria for reporting qualitative re-
search (COREQ) checklist was used to report the meth-
odology and findings of the study [20].
The research team consisted of one experienced qualita-
tive researcher who moderated all interviews and focus
groups, and four research assistants involved in note-
taking and transcribing the audiotapes. Apart from one
research assistant, all were female. Two research assistants
were medical doctors and two were non-medical, all with
some level of experience in conducting in-depth inter-
views (IDIs) and focus group discussions (FGDs). The
research team participated in a three-day refresher train-
ing on the background and rationale of the study, its ob-
jectives, ethical considerations and on strengthening
certain qualitative research techniques more specifically.
The topics that were covered in the interviews and
focus groups were beliefs and practices around child-
birth, community preference of birth care provider, birth
place, role of provider in antenatal, childbirth and post-
partum care, beliefs and practices around postpartum
haemorrhage and other complications, relationship with
health care providers, perspectives towards AMWs, and
provider and community perspectives towards task shift-
ing of misoprostol to AMWs. Final interview guides are
available at Additional file 1. Pre-testing of the interview
and focus group guides was done in Thanlyin Township
(a semi-rural area in Yangon Division) to identify the na-
ture of the interview/focus group and the content of the
interview or focus group guide. From the pre-test, it was
learnt that conducting FGDs with the AMWs in the hos-
pital setting was not conducive to the discussions as they
were reluctant to talk about issues related to relation-
ships with health care providers and actual practices in
the community. Therefore, apart from the two FGDs with
the MWs, which were done in the township hospital, all
the other FGDs were done in community gathering places
of the respective villages and the office of an international
NGO in Ngape Township. All the individual interviews
were done in private places chosen by the interviewee,
and were mostly carried out in the offices of interviewees.
Five advocacy meetings were undertaken with the
district and township level authorities before data were
collected. A total of ten key informants (three national
level health planners, five district and township level
health planners and implementers, and two from the
Three Millennium Development Goal (3MDG) fund who
were involved in maternal and child health program im-
plementation) were conducted. Moreover, 15 FGDs (two
with MWs, five with AMWs, four with community mem-
bers and four with mothers of children under the age of
three years) were done from both hard-to-reach and non-
hard-to-reach areas as the main dimension for sampling.
Each FGD consisted of between five and twelve partici-
pants. The criteria for categorization of the hard-to-reach
and non-hard-to-reach villages are based on the geograph-
ical hard-to-reach definition used by the 3MDG
programme based on scores allocated for travelling time
to the nearest facility, mode of travel, transport charges
and roads affected by seasonal variation. A total of 12
points are given and villages scoring 0 to 3 are considered
as non-hard-to-reach, while 4 and above as hard-to-reach
villages [21].
As all the research team members were Myanmar
nationals, there were no language or cultural barriers.
The process of the research team members explaining
ethical procedures and permissions granted to the par-
ticipants during the first session created reluctance
among many participants in the beginning of the inter-
views and focus groups, as they saw the interviewers as
academic professionals, creating a power imbalance.
This was mitigated by first talking to them about their
personal backgrounds and demonstrating an interest in
their views regarding the topic, which took around five
to ten minutes. It is still acknowledged that responses
from participants may have been influenced by their per-
ception of the research team.
All the FGDs were audio recorded with written
informed consent from the participants. Three inter-
viewees refused to be audio recorded; all other IDIs were
audio recorded. Note taking was done for all the inter-
views and FGDs. All audio recordings were transcribed
verbatim in Myanmar language from the digital re-
corders by the note takers and checked against field
notes for consistency. The durations of the FGDs and
IDIs ranged from 30 min to 90 min with an average dur-
ation of 50 min. Data were collected until it was felt that
data saturation was obtained. During the data collection
process, daily discussions were made around the main
themes using a matrix in Myanmar language. These dis-
cussions afforded the opportunity to undertake prelimin-
ary interpretation of the data collected while it was still
fresh in the minds of the research staff. Before the actual
coding, all transcripts were read and reread by the prin-
cipal author in Myanmar language and all the translated
versions of the transcripts were read and reread by the
other coders. Transcripts of FGDs were fully translated
into English before coding, while remaining data were
coded in Myanmar language using ATLAS.ti software.
Two data coders coded the transcripts. Reliability coding
was set at 80% agreement and the inter-coder reliability
was found to be over 80%. This approach balanced the
differing views of the researchers in the study. During
the time of coding, any unclear information regarding
the transcripts and context was verified and clarified
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with the primary author who has knowledge of the con-
text. The primary coding structure was developed
around conceptual codes and sub-codes identifying the
key concepts and essential dimensions of the main topic
domains. In some of the topics the sub-code level went
down to three levels under the main topic. Relationship
codes were also found identifying links between other
concepts coded with the conceptual codes. Participant
characteristics (key informants, MWs, AMWs, mothers
and community members) were also considered during
the coding process. Before finalising the code structure,
the two researchers who coded the transcripts collabora-
tively reviewed the coding structure and agreed on the
final version. Main themes were pre-identified using the
focus group discussion and the individual interview
guides and emerging themes were also noted and dis-
cussed. Quotations are used to support the study find-
ings and to enhance understanding of the local context.
Results
Study participants
Data were collected over a 7-month period between
July 2015 and February 2016. Ten participating key
informants came from the national Department of
Health, and from district and township level health
departments involved in maternal and child health
planning and implementation (Table 1). District and
regional level health departments provide supervisory
and technical support to the township level and guide
the process of AMW recruitment, supervision, train-
ing and decision making towards AMW roles and
tasks. Township level health departments mainly
manage the township health system which is the
backbone of primary health care, provide comprehen-
sive health services at the local level and is predomin-
antly responsible for management of the AMW
activities [22]. Key informants had between five and
37 years of experience in the health service.
Fifteen MWs and 33 AMWs participated in two and
five FGDs respectively. Thirty-six community members
participated in the FGDs, 18 being male and 18 female.
Community members comprised of local people who are
knowledgeable about their village such as community
leaders, teachers, village health committee members and
elders.
Community attitudes and practices towards childbirth
Our inquiry identified that many women in the study town-
ship preferred a home birth. The main reasons for choosing
a home birth were family and community support given at
the time of childbirth. In hard-to-reach villages, a village
was still perceived as one large family with social and trad-
itional closeness to one another. It was perceived that dur-
ing childbirth, women who may or may not be a relative
are always there to lend a helping hand. Participants in the
study mentioned that giving birth surrounded by relatives
and neighbours provided them with strength and courage.
“ ….when we have labour pain we call: “Mom, sisters,
please come. I have pain.” We also call the neighbours.
I feel strong and they cheer me and help me shout”
(a woman with four children in FGD with mothers)
Another reason given in favour of home births was that
there is no one to look after the children or household if
mothers would leave the house. For a facility delivery, there
tended to be a need for an accompanying person to look
after the woman and at the same time someone to look
after her children at home. Someone to stay with the
children or take care of the household during the facility
delivery was hard to find, while for home deliveries women
can easily come and attend the delivery as they live near to
one another and can come when they have free time.
“…they prefer home deliveries…..most of the people live
in the farms and not in the village…..who will look after
their live stocks like pigs and chickens…who will look
after their children?”
(AMW from non hard-to-reach village during FGD
with AMWs)
Community members and providers in hard-to-reach
areas mentioned long distances and travelling time to
reach the nearest hospital as a barrier to facility births.
In these areas, traveling to the nearest hospital could
take over 6–10 h of walking before reaching a road
Table 1 Overview of study participants of the focus group discussions and in-depth interviews
Category Number of Focus
Group Discussions
Total no of
participants
Age range of participants
Auxiliary Midwives (AMWs) 5 33 19–52 years
Midwives (MWs) 2 15 24–55 years
Mothers with children under three years of age 4 29 21–37 years
Community members 4 36 21–60 years
Key informants – 10 31–67 years
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where transport needs to be arranged. Women in these
hard-to-reach areas were described by MWs as the hard-
est community groups to send to hospital when requir-
ing emergency care. Planned facility based deliveries for
high-risk women are recommended by the AMWs and
MWs. It was reported that many of the women who
lived near a facility were more willing to go for a facility
delivery, whereas women in hard-to-reach areas only go
to a health facility for complications and emergencies.
“I got labour pain and waited for about 1 day and 1
night hoping to deliver the baby at home. The TBA
[traditional birth attendant] didn’t know what was
happening. When examined by the AMW and didn’t
see the head of the baby as well. I was told I must go
to the hospital… So, I hired the car and went to the
hospital”
(a woman who had facility delivery from hard-to-reach
area in the FGD with mothers)
It was not only due to distance, but also due to the
costs associated with transport and hospitalization.
Women reported that the only reason to give birth at a
facility was in situations of a life-threatening emergency.
“I had to go to the hospital because my placenta
did not come out after the baby was born… I was
scared but the AMW said we must go… or it will
cause my life”
(a woman who had complications during birth in the
FGD with mothers)
Care providers at home births
The main providers attending home births in the
study area are AMWs, MWs and traditional birth at-
tendants. Few reported on the use of traditional birth
attendants to manage the home deliveries. Currently,
traditional birth attendants are reported to be less
frequently used for assisting with deliveries, but con-
sidered as helpers for the daily cooking and cleaning
activities for some of the wealthier families in the vil-
lage. In villages where the MW is present, home
births are mainly attended by the MWs. However, in
villages where there is no MW, and particularly in
hard-to-reach areas, the main health care providers
for home births are AMWs. In some of the villages
where there are both MWs and AMWs, the AMWs
often assist the MWs during delivery.
“mostly the mothers call the AMWs first because they
live in the village but the AMWs under my supervision
always inform me with a phone and I also attend the
delivery together.”
(MW from a hard-to-reach area during FGD with MWs)
Perspectives towards AMWs
According to the mothers and the other community
members, AMWs were easily accessible as they lived
within the community. They described AMWs as ‘na-
tives who live close to them’ and who can be called
upon 24 h a day, seven days a week. Having a village-
owned AMW was considered an asset to the village.
Mothers in the community also mentioned that AMWs
are trustworthy and skilful members of the community.
AMWs are well-recognised by the community for their
care during the time of need not only for pregnant women
but for the village as a whole.
“She [AMW] lived in this village all her life. She
delivered all three of my babies and she is very
skilful. Also, she [AMW] has very good relationship
with [midwife] and if needed she also calls her
and attend the deliveries together.”
(Female community member during FGD with
community members)
Acceptability of AMWs was generally high among key
informants from all levels of the health system. MWs
and other township level health care providers men-
tioned that AMWs are promising health care providers
for the community, especially in the more remote areas
where there is no MW. MWs reported relying on the
AMWs for all services rendered to the mother and the
child and MWs appreciated their assistance.
“AMWs are essential especially in places where we
can’t go. Mothers may want to deliver with us… but in
reality it is very far and we cannot be there, so they
usually deliver with the AMWs. If they need help, they
send someone (flag person) to call us for help…. when
it comes to delivery, they [women] can’t wait and have
no time to call us in advance.”
(MW assigned to a hard-to-reach area during
FGD with MWs)
Community members and AMWs in the study men-
tioned that in some of the villages, MWs were only able
to come once a month for immunization. Reluctance of
MWs to stay in villages, and barriers to access resulting
from long distances and tough travelling circumstances
were major factors.
“Our village is quite far, although a midwife is
assigned, she rarely comes, she only comes for
immunization… not only her… none of the midwives
stayed. We have the rural health centre and we made
a house so that MWs would stay, but they don’t stay…
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it took you all to reach here half a day… in the rainy
season… is very tough”
(Community member from hard to reach village in the
FGD with community)
Community members indicated that they relied on the
AMWs because they were local women and readily
available for deliveries and in times of emergencies.
Although AMWs were considered as reliable health care
providers, some of the providers mentioned their
concerns about over-confidence of the AMWs in conduct-
ing health care activities.
“They [AMWs] think they can do all. We teach them
ethics in school, meaning in the training but they act
in the village as they were trained MW and say and
act like a MW. I mean, we teach them and tell them
what to follow ‘dos and don’ts’ during their training
but they act and do beyond what is taught.”
(Township level health care provider from key inform-
ant interview)
Experiences of post-partum haemorrhage by AMWs
Although postpartum haemorrhage is a rare event in
their daily practice, many of the AMWs in the study had
experienced one or more serious events of a patient with
severe bleeding, either in the community or at the hos-
pital, during their service years. AMWs mentioned the
events as unexpected and scary with serious ‘fear of
death’ as their main concern due to limited experience
and lack of available resources. The only measure
AMWs were trained in and able to provide was timely
referral to the nearest hospital and many felt helpless
when they actually encountered the bleeding. The
second level of care at rural health centres is not
equipped with the lifesaving facilities for a bleeding
woman in life-threatening danger Therefore, referral to a
tertiary care hospital seemed to be the only resource for
further care.
“…I felt so scared as she was bleeding heavily and the
MW told me to come to the hospital immediately and
I put my fist into the vagina to stop the bleeding and I
thought she was going to die”
(AMW from hard-to-reach village during FGD with
AMWs)
Current practices and management of post-partum
haemorrhage
Strong national guidelines exist for the government-
trained skilled birth attendants at the community level
(MWs) for the management of postpartum
haemorrhage. Oxytocin injection is widely used in the
facility settings, and is the intervention of choice. Man-
agement of postpartum haemorrhage at the community-
level varied between MWs: most use 10 units of intra-
muscular oxytocin injection for prevention of postpar-
tum haemorrhage, while a few MWs mentioned using
misoprostol immediately after birth. The law prohibits
AMWs from administering any injections, and current
national guidelines do not support the use of misopros-
tol by AMWs. Misoprostol was introduced into the
township health system around 2012. In the study
Township, the drug became widely available with the
introduction of the 3MDG program in 2014. One of the
township level key informants described the availability
of the drug as follows:
“Nowadays, we have plenty of misoprostol and we
mainly distribute to the MWs. For the AMWs,
although it is in their manual, there is no clear
guideline for distribution and usage by the central
health authority… so what should we do”
(Township level health care provider from key inform-
ant interview)
AMWs also seemed uncertain about how and where
to procure it. An AMW from a rural area stated:
“…we are willing to give misoprostol to the mothers,
but currently only the MW give it, we are not allowed
to give it…and we don’t have the drug either”
(AMW in hard-to-reach area during FGD with
AMWs)
According to the district level key informant inter-
views, each township seemed to have different practices
with respect to misoprostol according to the township
medical officer’s authority. In the study township, there
seemed to be no restriction on the distribution of miso-
prostol to the AMWs by the MWs.
“…the trend is changing [meaning involving all
community base health workers] and we allow them
[AMWs] to deliver non risk cases, you see old ones
[AMWs] are delivering well and I think giving
misoprostol would not be a bad idea. You see if our
midwives are allowed to use misoprostol and they
[AMWs] are not, it is hard for them to survive in the
community. Our midwives give drugs and they
[AMWs] are only allowed to rub the abdomen. I think
that is not fair, they are the main persons in the
community.”
(Township level health care provider from key inform-
ant interview)
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MWs in the study similarly mentioned that they were
willing to give misoprostol to AMWs. Some of the MWs
in the study had already distributed misoprostol to
AMWs, especially in hard-to-reach areas and to those
whom they trust.
“We give the misoprostol together with the CDK [clean
delivery kit] to all the AMWs in our areas. For those
who are near to us, there is no problem because it is
easy to monitor and refer if needed. But for those in
the hill hard-to-reach, there is no-one apart from
them. We tell them again and again when to give the
drug [misoprostol], only after the birth of the baby and
not to use it any other time”
(MW assigned in the hard-to-reach area during FGD
with MWs)
However, some of the key informant interviewees
mentioned that they worried about the misuse of miso-
prostol to induce abortion, but MWs and AMWs in the
FGDs did not mention anything in relation to abortion,
potentially because induced abortions are illegal in
Myanmar and are therefore a highly sensitive topic.
“I always tell the AMWs to give the drug [misoprostol]
only after the baby is born as it is very dangerous if is
given before the delivery of the baby and because they
are away from me during the time of the actual birth.
I worry that they would use it early”
(MW from hard-to-reach area during FGD with
MWs)
One of the reasons for this concern was that the drug’s
commonly used name in Myanmar language, “tha ein
pwint say” (the ein: uterus; pwint: open; say: medicine),
literally means “a drug that enhances the opening of the
uterus”, creating misunderstanding among the users.
Thus it was now purposely referred to as “tha ein kyunte
say” (the ein: uterus; kyunte: contract; say: medicine),
literally meaning contraction of the uterus, in most of
the trainings.
“You see they [AMWs] know it as “Tha ein pwint say”
and we are worried that they would use it before
delivery thinking that it will enhance labour. So we
emphasize in the training as “tha ein kyunte say” and
we stress that it can only be given after the birth of the
baby”
(Township level trainer of AMWs from key informant
interview)
AMWs in the FGDs stated that they are willing and
confident to take on the task of administering misopros-
tol during home deliveries. In addition, many of the
AMWs expressed their frustration about not being
allowed to provide any drugs to help a woman who is
relying on her for care in time of danger.
“When something happens, they [mothers] are with
sad faces. They come to us with a small face [meaning
a look of helplessness] saying we need you to treat us…
The thing is that it is not that we cannot do it [give
misoprostol], but we are not allowed to do it and we
are scared to do it [scared of being punished rather
than scared of giving the drug] …we are afraid”
(AMW in hard-to-reach area during FGD with AMWs)
AMWs in the study considered that giving this life-
saving drug would increase not only trust by the com-
munity but also increase their self-confidence in man-
aging deliveries. However, some of the AMWs in the
study highlighted the need for refresher training about
postpartum haemorrhage and standardized dosage
guidelines in using misoprostol.
“we need training on postpartum haemorrhage and
also how to prevent and treat before referring as is a
life threatening event. We are confident to give the
drug if we are trained properly and clearly teach us on
how many tablets to give and when to give… we will
follow what is taught”
(AMW in hard-to-reach area during FGD with AMWs)
It became clear that there are no consistent guidelines
at township level for distribution of misoprostol. The
township level health care providers mentioned that they
would be willing to distribute misoprostol to the AMWs
if there was a clear written approval from the national
level health authorities regarding the dosage and timing
of drug delivery. Providers stressed that misoprostol
should only be distributed to AMWs after systematic
training about the benefits, side effects and correct time
for usage.
Training of AMW
According to the most recent AMW training curriculum
in Myanmar, AMWs are taught a three-months theory
and three-months practical training at the township or
the respective station hospitals. Although delivery and
postpartum care are meant to be taught through three
hour long theoretical lectures each with 20 h of practical
training, most of the participants in the study stated that
theory was taught in a one-way lecturing format with
minimal supervised practical training. Active manage-
ment of the third stage of labour had been included in
the training, however information provided for the use
of misoprostol was inconsistent. Within the last five
years, there have been three versions of the standard
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training guidelines in which the dose of misoprostol was
different. The first guideline stated two tablets (400 μg),
the second guideline did not specify the dosage and the
latest guideline stated three tablets (600 μg) immediately
after the birth of the baby. As a result, within the same
township, AMWs had access to conflicting guidelines.
“No, it [management of postpartum haemorrhage] was
not taught… we were told to give [misoprostol] after
the birth of the baby… not really clear explanation.”
(AMW from non-hard-to-reach area during FGD with
AMWs)
As a result, some of the AMWs explained that because
the training was not clear, they had no option but to just
refer patients to the health facility.
“we don’t wait…we just refer as early as possible if is
of risk…like multipara…”
(AMW from non-hard-to-reach area during FGD with
AMWs)
The information about the use of misoprostol as part of
active management of third stage of labour by AMWs is
included in the latest 2015 curriculum for AMWs, using a
WHO standard dose of 600 μg (3 tablets) after the birth of
the baby. However, the manual does not specifically state
that AMW are allowed to administer misoprostol. On-
going refresher trainings and newly trained AMWs in
2015 are said to be using the new guidelines.
Discussion
Our work sought to reignite discussion on the potential for
task shifting of misoprostol administration to AMWs by in-
vestigating the acceptability and feasibility of this interven-
tion. The findings showed that AMWs generally were
trained on the active management of third stage of labour,
including the use of misoprostol, but not all AMWs re-
ported using misoprostol in practice. Supportive reasons
for task shifting administration of oral misoprostol to
AMWs included discussions around the good relationship
and trust between AMWs and MWs, whereby MWs felt
confident distributing misoprostol to AMWs. However, the
lack of clear government-level written permission to dis-
tribute the drug was perceived as a barrier to task shifting.
Overall in Myanmar, postpartum haemorrhage remains
the leading cause of maternal mortality, accounting for
30% of maternal deaths. Equipping AMWs with the skills
and resources to effectively prevent postpartum haemor-
rhage will be an essential component of efforts to reduce
the incidence of postpartum haemorrhage. Although
WHO guidelines recommend delivery of an injection of
oxytocin as the first-line pharmacotherapy for the preven-
tion and treatment of postpartum haemorrhage, the law in
Myanmar restricts the use of injections by AMWs. Oral
misoprostol is also an effective drug for the prevention of
postpartum haemorrhage and is recommended by the
WHO as a drug that could be used by AMWs in
resource-limited settings [17]. Studies have also found that
community-based distribution of misoprostol using a
community level health worker was effective for preven-
tion of postpartum haemorrhage [23–25]. According to a
study done by Thein Thein Htay in 2007, the use of oral
misoprostol by MWs at the community level has proven
to be safe and effective for prevention of postpartum
haemorrhage in Myanmar since 2007 and was considered
for nationwide distribution to MWs and AMWs [26].
However, competing priorities such as disease control ac-
tivities over the past decade and frequent changes in
policy-makers have hampered progress towards this goal.
A major enabling factor to task shifting misoprostol ad-
ministration to AMWs was the recognition amongst com-
munity members, healthcare providers and policy makers
of the critical role played by AMWs in providing care dur-
ing childbirth, particularly in hard-to-reach areas. Home
births remain common in Myanmar with over 70% of de-
liveries occurring outside of a health facility [27]. Our
findings suggest this to be due to a combination of factors
including convenience, cultural preference and significant
geographical constraints, which restrict the accessibility of
healthcare facilities by people in the hard to reach areas.
Thus the roles of MWs and AMWs are essential as these
community-based providers are often called upon to
attend home births. Studies have also shown that
community health workers are competent not only in
pregnancy and childbirth practices, but also in providing
other health related services such as nutrition promotion,
immunization and disease control activities [28, 29].
In our study area, AMWs were considered by commu-
nity members and key informants to be capable providers
of care during childbirth. As such, distribution of oral
misoprostol to AMWs was considered by the midwives
and key informants sampled in this study to be a poten-
tially effective and feasible option for the prevention of
postpartum haemorrhage where skilled birth attendants
are not available. AMWs themselves reported to be able
and willing to take on the task of misoprostol administra-
tion and welcomed the opportunity to expand their cap-
acity to provide improved care during delivery.
A number of barriers to task shifting of misoprostol to
AMWs were identified by study participants. Some key
informants mentioned fear of untimely misoprostol use
before the child is born, or when used to induce abor-
tion, particularly if sufficient training and standardised
policies and procedures were not in place. Interestingly,
the use of misoprostol to induce abortion was not men-
tioned by MWs and AMWs, likely because they know it
is illegal to use misoprostol for this indication. Studies
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on the use of misoprostol for prevention of postpartum
haemorrhage have helped to address these concerns, and
a comprehensive review of 18 programs using lay health
care workers to provide misoprostol found very low
rates of incorrect use [23–25]. This suggests that AMWs
in Myanmar have considerable potential to administer
misoprostol correctly if provided with sufficient training.
AMWs themselves also spoke about inconsistent quality
of training, and some highlighted a paucity of informa-
tion in their training regarding postpartum haemorrhage
and the rationale for using misoprostol. A review done
by Prata et al. in 2013 stated that along with a national
policy and drug distribution mechanisms for misopros-
tol, adequate provision of information and training
should be included for lay health workers and the com-
munity [23]. The findings suggest that MWs and
township-level health providers would be confident in
the ability of AMWs to administer misoprostol correctly
with additional refresher trainings. Some of the AMWs
in our study were already administering misoprostol, fur-
ther highlighting the need for clear guidelines, consistent
policies and adequate training.
This study suggests that oral misoprostol is a viable
option to prevent postpartum haemorrhage especially
for hard-to-reach areas where AMWs are the primary
attendants for home births.
Limitations of the study
The study township was purposively selected based
on its ‘hard-to-reach’ characteristics and as such, find-
ings might not be representative of the perspectives
of equivalent stakeholders in other townships in
Myanmar, potentially limiting generalization of the
findings to other areas. The relationships between the
AMWs and the MWs in the study were very positive
and it may be due to the social desirability bias of
their relationship that actual practice may vary.
Conclusion
With over 30% of the maternal deaths in Myanmar
due to postpartum haemorrhage, it is time that health
planners consider this evidence-based intervention for
scale-up throughout the country. The findings of this
study support the feasibility of task shifting of miso-
prostol to AMWs as a crucial intervention for the
prevention of postpartum haemorrhage in Myanmar.
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